Dynavax proposes follow-on, begins search for new CEO

Dynavax Technologies Corp. (NASDAQ:DVAX) announced a proposed follow-on late Tuesday and said it plans to add experienced commercial leadership to its management team, including a new CEO. After a recommendation from CEO Dino Dina, Dynavax's board will begin searching for a successor. Dina will remain CEO throughout the search and will continue as a director once a successor is named. Dynavax said the changes are in preparation for an independent launch of Heplisav in the U.S. Last month, the company submitted a BLA to FDA for the product to prevent HBV infection caused by all known subtypes in adults 18-70 years of age. Dynavax requested Priority Review for the application. ...